NASDAQ:AKAN - Nasdaq - CA00971M4039 - Common Stock - Currency: USD
NASDAQ:AKAN (3/7/2025, 8:04:24 PM)
1.6
-0.05 (-3.03%)
The current stock price of AKAN is 1.6 USD. In the past month the price decreased by -4.19%. In the past year, price decreased by -88.86%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 26.18 | 386.95B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
PFE | PFIZER INC | 8.59 | 151.49B | ||
SNY | SANOFI-ADR | 14.24 | 148.55B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
GSK | GSK PLC-SPON ADR | 8.29 | 81.62B | ||
ZTS | ZOETIS INC | 28.78 | 76.29B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The firm's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The firm also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The firm also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 107
Company Website: https://akandacorp.com/
Investor Relations: https://www.akandacorp.com/investors/
Phone: 442034889514
The current stock price of AKAN is 1.6 USD. The price decreased by -3.03% in the last trading session.
The exchange symbol of AKANDA CORP is AKAN and it is listed on the Nasdaq exchange.
AKAN stock is listed on the Nasdaq exchange.
AKANDA CORP (AKAN) has a market capitalization of 1.78M USD. This makes AKAN a Nano Cap stock.
AKANDA CORP (AKAN) currently has 107 employees.
AKANDA CORP (AKAN) has a support level at 1.59 and a resistance level at 1.69. Check the full technical report for a detailed analysis of AKAN support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AKAN does not pay a dividend.
AKANDA CORP (AKAN) will report earnings on 2022-12-13, before the market open.
AKANDA CORP (AKAN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-286.63).
The outstanding short interest for AKANDA CORP (AKAN) is 4.35% of its float. Check the ownership tab for more information on the AKAN short interest.
ChartMill assigns a technical rating of 1 / 10 to AKAN. When comparing the yearly performance of all stocks, AKAN is a bad performer in the overall market: 92.26% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to AKAN. Both the profitability and financial health of AKAN have multiple concerns.
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -286.63. The EPS decreased by -83.91% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -323.87% | ||
ROE | -706.22% | ||
Debt/Equity | 0.08 |